Hengrui Sun

423 total citations
8 papers, 334 citations indexed

About

Hengrui Sun is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Hengrui Sun has authored 8 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Physiology and 2 papers in Immunology. Recurrent topics in Hengrui Sun's work include Protein Kinase Regulation and GTPase Signaling (2 papers), Cancer therapeutics and mechanisms (1 paper) and Meta-analysis and systematic reviews (1 paper). Hengrui Sun is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (2 papers), Cancer therapeutics and mechanisms (1 paper) and Meta-analysis and systematic reviews (1 paper). Hengrui Sun collaborates with scholars based in United States, Italy and China. Hengrui Sun's co-authors include Mack H. Wu, Jerome W. Breslin, Sarah Y. Yuan, Jun Zhu, Steven L. Young, Lucy A Clunes, Robert Tarran, Julia E. Rasmussen, Ingrid Fricks and Seiko F. Okada and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Infectious Diseases and Journal of Medicinal Chemistry.

In The Last Decade

Hengrui Sun

8 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hengrui Sun United States 6 154 93 67 47 43 8 334
Harika Sabbineni United States 12 344 2.2× 98 1.1× 36 0.5× 66 1.4× 41 1.0× 16 535
Sandeep Artham United States 13 211 1.4× 85 0.9× 29 0.4× 65 1.4× 55 1.3× 23 421
Takehiko Takayanagi United States 9 134 0.9× 79 0.8× 30 0.4× 37 0.8× 7 0.2× 12 365
Dario F. Riascos‐Bernal United States 11 184 1.2× 73 0.8× 65 1.0× 85 1.8× 20 0.5× 23 394
Patrick Albert United States 5 145 0.9× 27 0.3× 34 0.5× 107 2.3× 15 0.3× 5 328
Mabruka Alfaidi United States 11 138 0.9× 26 0.3× 25 0.4× 101 2.1× 14 0.3× 18 317
Xingning Lai China 9 233 1.5× 40 0.4× 44 0.7× 51 1.1× 12 0.3× 12 376
Isaac Rosa Spain 14 288 1.9× 61 0.7× 45 0.7× 43 0.9× 63 1.5× 20 556
Hideo Yoshizaki Japan 7 251 1.6× 34 0.4× 38 0.6× 22 0.5× 7 0.2× 16 397
Constanze Blume Germany 5 140 0.9× 31 0.3× 77 1.1× 60 1.3× 18 0.4× 6 377

Countries citing papers authored by Hengrui Sun

Since Specialization
Citations

This map shows the geographic impact of Hengrui Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengrui Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengrui Sun more than expected).

Fields of papers citing papers by Hengrui Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengrui Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengrui Sun. The network helps show where Hengrui Sun may publish in the future.

Co-authorship network of co-authors of Hengrui Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Hengrui Sun. A scholar is included among the top collaborators of Hengrui Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengrui Sun. Hengrui Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chen, Xiaoli, Hengrui Sun, Kaniel Cassady, et al.. (2021). The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety. Frontiers in Oncology. 11. 683263–683263. 11 indexed citations
2.
Thomas, Sonia, et al.. (2020). Enhancing clarity of clinical trial safety reports for data monitoring committees. Journal of Biopharmaceutical Statistics. 30(6). 1147–1161. 1 indexed citations
3.
Harrington, Patrick R., Takashi Komatsu, Hengrui Sun, & Lisa K. Naeger. (2019). Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic Assays. Clinical Infectious Diseases. 70(2). 327–330. 2 indexed citations
4.
Barthel, Benjamin L., Zhiyong Zhang, Christopher D. Coldren, et al.. (2009). Preclinical Efficacy of a Carboxylesterase 2-Activated Prodrug of Doxazolidine. Journal of Medicinal Chemistry. 52(23). 7678–7688. 24 indexed citations
5.
Sun, Hengrui, Lucy A Clunes, Julia E. Rasmussen, et al.. (2008). 17β-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. Journal of Clinical Investigation. 118(12). 4025–35. 76 indexed citations
6.
Sun, Hengrui, Jerome W. Breslin, Jun Zhu, Sarah Y. Yuan, & Mack H. Wu. (2006). Rho and ROCK Signaling in VEGF‐Induced Microvascular Endothelial Hyperpermeability. Microcirculation. 13(3). 237–247. 135 indexed citations
7.
Breslin, Jerome W., Hengrui Sun, Wenjuan Xu, et al.. (2005). Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage. American Journal of Physiology-Heart and Circulatory Physiology. 290(2). H741–H750. 51 indexed citations
8.
Zhu, Jun, Vitaly Balan, Agnieszka Bronisz, et al.. (2005). Identification of Raf-1 S471 as a Novel Phosphorylation Site Critical for Raf-1 and B-Raf Kinase Activities and for MEK Binding. Molecular Biology of the Cell. 16(10). 4733–4744. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026